Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Diabetologia ; 55(3): 579-88, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22234648

ABSTRACT

AIMS/HYPOTHESIS: A positive impact of exercise intervention programmes on quality of life (QoL) may be important for long-term patient compliance to exercise recommendations. We have previously shown that QoL improves significantly with supervised exercise, whereas it worsens with counselling alone, in patients with type 2 diabetes from the Italian Diabetes and Exercise Study (IDES). Here, we report data on the relationship between changes in QoL and volume of physical activity/exercise in these individuals. METHODS: This multicentre parallel randomised controlled, open-label, trial enrolled sedentary patients with type 2 diabetes (n = 606 of 691 eligible) in 22 outpatient diabetes clinics. Patients were randomised by centre, age and diabetes treatment using a permuted-block design to twice-a-week supervised aerobic and resistance training plus exercise counselling (exercise group) versus counselling alone (control group) for 12 months. Health-related QoL was assessed by the 36-Item Short Form (SF-36) Health Survey. RESULTS: In the exercise group (n = 268 of 303 randomised), there was a trend for increasing QoL with increasing exercise volume, with significant improvement of the physical component summary (PCS) measure only above 17.5 metabolic equivalents h⁻¹ week⁻¹ and a clear volume-relationship for the mental component summary (MCS) measure. A relationship with volume of physical activity also was observed in the control group (n = 260 of 303 randomised), despite overall deterioration of all scores. Independent correlates of improvements in both PCS and MCS were exercise volume, study arm and, inversely, baseline score. CONCLUSIONS/INTERPRETATION: This large trial shows a relationship between changes in physical and mental health-related QoL measures and volume of physical activity/exercise, with supervised exercise training also providing volume-independent benefits.


Subject(s)
Diabetes Mellitus, Type 2/psychology , Diabetes Mellitus, Type 2/therapy , Exercise/psychology , Fitness Centers/methods , Quality of Life , Body Mass Index , Cohort Studies , Diabetes Mellitus, Type 2/blood , Female , Glycated Hemoglobin/analysis , Humans , Italy , Life Style , Male , Middle Aged , Patient Education as Topic , Psychiatric Status Rating Scales , Resistance Training , Sedentary Behavior , Surveys and Questionnaires
2.
Neuroradiol J ; 24(3): 345-9, 2011 Jun 30.
Article in English | MEDLINE | ID: mdl-24059656

ABSTRACT

Perilesional edema (PE) is commonly observed in association with an intracranial mass. PE is thought to be determined by vasogenic effects in the cerebral parenchyma surrounding the mass due to the loss or absence of the blood-brain barrier (BBB) inside the lesion. Alterations in capillary permeability induce extrusion of fluids into the extravascular space around the mass. On Computed Tomography (CT) PE corresponds to an area of low density for the increased water content, outside the margins of the lesion. It is difficult to differentiate PE from areas of parenchymal compressive ischemia and sometimes the two events could be associated. A solitary mass with PE is more commonly discovered on a non-enhanced computed tomography (NECT) study performed for the onset of stable or rapidly progressive neurological symptoms. In such cases, a supplementary CT scan with contrast (CECT) is generally indicated to complete the baseline imaging before MRI. Contrast enhancement is generally present in a mass with PE and it is not specific for differential diagnosis. Perfusion computed tomography (PCT) requires a few minutes in addition to the time needed for CECT. PCT may give information on regional microvascular density, permeability and blood flow, thus it may play a role when tumoral neo-angiogenesis or non-neoplastic altered haemodynamics are suspected. We therefore investigated the utility of PCT in the differential diagnosis of the intracranial solitary masses with PE.

3.
Diabetes Metab Res Rev ; 25 Suppl 1: S11-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19662620

ABSTRACT

Cardiorespiratory fitness, which is determined mainly by the level of physical activity, is inversely related to mortality in the general population as well as in subjects with diabetes, the incidence of which is also increased by low exercise capacity. Exercise is capable of promoting glucose utilization in normal subjects as well as in insulin-deficient or insulin-resistant diabetic individuals. In diabetic subjects treated with insulin or insulin secretagogues, exercise may also result in complications, with too much insulin causing hypoglycaemia and not enough insulin leading to hyperglycaemia and possibly ketoacidosis; both complications may also occur several hours after exercise. Therefore, self-monitoring of blood glucose before, during (for exercise duration of more than 1 h) and after physical exercise is highly recommended, and also carbohydrate supplementation may be required. In the Italian Diabetes Exercise Study (IDES), measurement of blood glucose and systolic and diastolic blood pressure levels before and after supervised sessions of combined (aerobic + resistance) exercise in type 2 diabetic subjects with the metabolic syndrome showed significant reductions of these parameters, though no major hypoglycaemic or hypotensive episode was detected. The extent of reduction of blood glucose was related to baseline values but not to energy expenditure and was higher in subjects treated with insulin than in those on diet or oral hypoglycaemic agents (OHA). Thus, supervised exercise training associated with blood glucose monitoring is an effective and safe intervention to decrease blood glucose levels in type 2 diabetic subjects.


Subject(s)
Blood Glucose Self-Monitoring , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/physiopathology , Diabetes Mellitus/blood , Diabetes Mellitus/physiopathology , Exercise , Self Care , Cardiovascular Diseases/prevention & control , Diabetes Mellitus/mortality , Diabetic Angiopathies/prevention & control , Diet, Diabetic , Glucose/metabolism , Homeostasis , Humans , Multicenter Studies as Topic , Muscle, Skeletal/metabolism , Muscle, Skeletal/physiology , Physical Fitness , Randomized Controlled Trials as Topic
4.
J Neurol Neurosurg Psychiatry ; 79(11): 1249-54, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18535022

ABSTRACT

BACKGROUND: Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by deficiency of alpha-galactosidase A. Central nervous system (CNS) manifestations consist mainly of cerebrovascular events. Brain MRI results are often abnormal. PURPOSE: The aim of the study was to describe CNS involvement in a group of Italian patients with AFD. METHODS: Clinical and brain MRI data of 43 patients with AFD (25 men, 41.94+/-10.83 years old and 18 women, 52.48+/-17.50 years old) were analysed retrospectively. 17 male patients and 7 female patients were under treatment with enzyme replacement therapy (ERT). RESULTS: All 43 patients had signs or symptoms of AFD. 16 men (64%) and 13 women (72%) demonstrated CNS involvement, although with varying severity. Overall, 6 men and 5 women had suffered from cerebrovascular accidents with an age at onset of 33.64+/-13.65 years and 53.68+/-11.71 years, respectively. Brain MR images were abnormal in 16/25 men and in 13/16 women. During CNS monitoring, some patients receiving ERT (5/17 men and 2/6 women) demonstrated neurological deterioration, especially those who had presented with cerebrovascular disease already before starting ERT. CONCLUSIONS: The study demonstrated a high frequency of CNS involvement in homozygous and heterozygous AFD patients, often characterised by early age at onset and abnormal brain MRIs. At present, ERT is widely used; however, potential beneficent effects may be disguised by the progression of irreversible pathology in short-term follow-up. Therefore, primary and secondary prophylaxes of cerebrovascular disease are extremely important.


Subject(s)
Brain/pathology , Fabry Disease/pathology , Magnetic Resonance Imaging , Adult , Age of Onset , Central Nervous System/pathology , Central Nervous System/physiopathology , Disease Progression , Fabry Disease/epidemiology , Fabry Disease/physiopathology , Female , Humans , Ischemic Attack, Transient/epidemiology , Male , Middle Aged , Retrospective Studies , Risk Factors , Severity of Illness Index
5.
Diabetologia ; 50(12): 2591-9, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17901943

ABSTRACT

AIMS/HYPOTHESIS: Podocyte loss by apoptosis, in addition to favouring progression of established diabetic nephropathy, has been recently indicated as an early phenomenon triggering the initiation of glomerular lesions. This study aimed to assess the rate of glomerular cell death and its relationship with renal functional, structural and molecular changes in rats with experimental diabetes. METHODS: Male Sprague-Dawley rats with streptozotocin-induced diabetes and coeval non-diabetic control animals were killed at 7 days and at 2, 4 and 6 months for the assessment of apoptosis, renal function, renal structure and the expression of podocyte markers and apoptosis- and cell cycle-related proteins. RESULTS: Glomerular cell apoptosis was significantly increased in diabetic vs non-diabetic rats at 4 months and to an even greater extent at 6 months, with podocytes accounting for 70% of apoptosing cells. The increase in apoptosis was preceded by increases in proteinuria, albuminuria and mean glomerular and mesangial areas, and by reductions in glomerular cell density and content of synaptopodin and Wilms' tumour protein-1. It coincided with the development of mesangial expansion and glomerular sclerosis, and with the upregulation/activation both of tumour protein p53, which increased progressively throughout the study, and of p21 (also known as cyclin-dependent kinase inhibitor 1A, CIP1 and WAF1), which peaked at 4 months and decreased thereafter. CONCLUSIONS/INTERPRETATION: Glomerular cell (podocyte) apoptosis is not an early feature in the course of experimental diabetic glomerulopathy, since it is preceded by glomerular hypertrophy, which may decrease glomerular cell density to the point of inducing compensatory podocyte hypertrophy. This is associated with reduced podocyte protein expression (podocytopathy) and proteinuria, and ultimately results in apoptotic cell loss (podocytopenia), driving progression to mesangial expansion and glomerular sclerosis.


Subject(s)
Apoptosis/physiology , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/physiopathology , Diabetic Nephropathies/etiology , Kidney Glomerulus/physiology , Podocytes/physiology , Streptozocin , Albuminuria/etiology , Animals , Blood Glucose/metabolism , Body Weight/physiology , Cell Cycle/genetics , Creatinine/blood , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/metabolism , Diabetic Nephropathies/blood , Genes, p53 , Kidney Glomerulus/pathology , Male , Microfilament Proteins/metabolism , Podocytes/pathology , Proteinuria/etiology , Rats , Rats, Sprague-Dawley
6.
Eur J Nucl Med Mol Imaging ; 32(4): 405-13, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15549298

ABSTRACT

PURPOSE: The aim of this study was to evaluate the suitability of [11C]SCH442416 for the in vivo imaging of adenosine A2A receptors. METHODS: In rats and Macaca nemestrina, we evaluated the time course of the cerebral distribution of [11C]SCH442416. Furthermore, in rats we investigated the rate of metabolic degradation, the inhibitory effects of different drugs acting on adenosine or dopamine receptors and the modification induced by the intrastriatal administration of quinolinic acid (QA). RESULTS: The rate of metabolic degradation of [11C]SCH442416 in rats was slow; 60 min after tracer injection, more than 40% of total plasma activity was due to unmetabolised [11C]SCH442416. At the time of maximum uptake, radioactive metabolites represented only 6% of total extractable activity in the cerebellum and less than 1% in the striatum. In the striatum, the region with the highest expression of A2A receptors, the in vivo uptake of [11C]SCH442416 was significantly reduced only by drugs acting on A2A receptors or by QA, a neurotoxin that selectively reduces the number of intrastriatal GABAergic neurons. Position emission tomography (PET) studies in monkeys indicated that the tracer rapidly accumulates in brain, reaching maximum uptake between 5 and 10 min. Twenty minutes after the injection, radioactivity concentration in the striatum was two times that in the cerebellum. CONCLUSION: The specificity of binding, the rank order of regional distribution in the brain of rats and M. nemestrina, the good signal to noise ratios and the low amount of radioactive metabolites in brain and periphery indicate that [11C]SCH442416 is a promising tracer for the in vivo imaging of A2A adenosine receptors using PET.


Subject(s)
Brain Diseases/diagnostic imaging , Brain Diseases/metabolism , Corpus Striatum/diagnostic imaging , Corpus Striatum/metabolism , Pyrazoles/pharmacokinetics , Pyrimidines/pharmacokinetics , Receptor, Adenosine A2A/metabolism , Animals , Brain Diseases/chemically induced , Carbon Radioisotopes/pharmacokinetics , Macaca nemestrina , Male , Metabolic Clearance Rate , Quinolinic Acid , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Rats , Species Specificity , Tissue Distribution
7.
Neurochem Int ; 44(6): 433-40, 2004 May.
Article in English | MEDLINE | ID: mdl-14687608

ABSTRACT

The peripheral-type benzodiazepine receptors (PBRs) are only minimally expressed in normal brain parenchyma, where they are primarily localized in glial cells. Their basal expression rises in different neurodegenerative disorders, due to the presence of infiltrating inflammatory cells and activated microglia. [11C]PK11195, a selective PBR antagonist, has been used for the in vivo PET monitoring of neurodegeneration in clinical observations. We recently developed and labeled with carbon-11 three new carboxamide derivatives: [11C]VC193M, [11C]VC195 and [11C]VC198M. Aim of this study was to evaluate these ligands for the in vivo measuring of PBRs expression in neurodegenerations and compare their kinetic behavior with that of the reference tracer [11C]PK11195. Radioligands were evaluated in a preclinical model of Huntington's disease consisting in the monolateral striatal injection of quinolinic acid (QA). Activated microglia and astrocytic gliosis was present only within the affected striatum. A concomitant increase in radioactivity accumulation was observed for all the tracers examined (P<0.01). Among the new compounds, [11C]VC195 showed higher levels of lesioned/unlesioned striatum ratios (3.28+/-0.44), in comparison with [11C]VC193M and [11C]VC198M (2.69+/-0.53 and 1.52+/-0.36, respectively), but slightly inferior to that observed for [11C]PK11195 (3.76+/-1.41).In conclusion, the results of the study indicate that [11C]VC195 is a promising candidate for in vivo PET monitoring of neurodegenerative processes but its in vivo behavior overlap that of [11C]PK11195.


Subject(s)
Amides/metabolism , Neurodegenerative Diseases/diagnostic imaging , Quinolines/metabolism , Radiopharmaceuticals/metabolism , Tomography, Emission-Computed , Amides/blood , Amides/pharmacokinetics , Animals , Immunohistochemistry , Isoquinolines/pharmacology , Ligands , Male , Quinolines/blood , Quinolines/pharmacokinetics , Radiopharmaceuticals/blood , Radiopharmaceuticals/pharmacokinetics , Rats
8.
J Med Chem ; 44(4): 579-85, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11170647

ABSTRACT

The novel quinoline-2-carboxamide derivatives N-[methyl-11C]-3-methyl-4-phenyl-N-(phenylmethyl)quinoline-2-carboxamide ([11C]4), (+/-)-N-[methyl-11C]-3-methyl-N-(1-methylpropyl)-4-phenylquinoline-2-carboxamide ([11C]5), and (+/-)-N-[methyl-11C]-3-methyl-4-(2-fluorophenyl)-N-(1-methylpropyl)quinoline-2-carboxamide ([11C]6) were labeled with carbon-11 (t1/2 = 20.4 min, beta+ = 99.8%) as potential radioligands for the noninvasive assessment of peripheral benzodiazepine type receptors (PBR) in vivo with positron emission tomography (PET). The radiosynthesis consisted of N-methylation of the desmethyl precursors 3-methyl-4-phenyl-N-(phenylmethyl)quinoline-2-carboxamide (4a), (+/-)-3-methyl-N-(1-methylpropyl)-4-phenylquinoline-2-carboxamide (5a), and (+/-)-4-(2-fluorophenyl)-3-methyl-N-(1-methylpropyl)quinoline-2-carboxamide (6a) with either [11C]methyl iodide or [11C]methyl triflate in the presence of tetrabutylammonium hydroxide or potassium hydroxide in dimethylformamide. The radioligands [11C]4, [11C]5, and [11C]6 were synthesized with over 99% radiochemical purity in 30 min, 30 +/- 5% radiochemical yield, calculated at the end of synthesis (EOS) non-decay-corrected, and 2.5 +/- 1.2 Ci/micromol of specific radioactivity. Inhibition studies in rats following intravenous pre-administration of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK 11195, 1) showed high specific binding to PBR of [11C]4, [11C]5, and [11C]6 in heart, lung, kidney, adrenal gland, spleen, and brain. The biological data suggest that [11C]5, [11C]6, and particularly [11C]4 are promising radioligands for PBR imaging in vivo with PET.


Subject(s)
Amides/chemical synthesis , Quinolines/chemical synthesis , Radiopharmaceuticals/chemical synthesis , Receptors, GABA-A/metabolism , Amides/chemistry , Amides/metabolism , Animals , Carbon Radioisotopes , Isotope Labeling , Ligands , Male , Methylation , Quinolines/chemistry , Quinolines/metabolism , Radiopharmaceuticals/chemistry , Radiopharmaceuticals/metabolism , Rats , Tissue Distribution , Tomography, Emission-Computed
9.
Neurochem Int ; 38(2): 169-80, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11137886

ABSTRACT

(+/-)-1-[4-(2-Isopropoxyethoxymethyl)-phenoxy]-3-isopropylamino-2-propanol (bisoprolol) is a potent, clinically used beta(1)-adrenergic agent. (R)-(+) and (S)-(-) enantiomers of bisoprolol were labelled with carbon-11 (t(1/2)=20.4 min) as putative tracers for the non-invasive assessment of the beta(1)-adrenoceptor subtype in the human heart and brain with positron emission tomography (PET). The radiosynthesis consisted of reductive alkylation of des-iso-propyl precursor with [2-11C]acetone in the presence of sodium cyanoborohydride and acetic acid. The stereo-conservative synthesis of (R)-(+) and (S)-(-)-1-[4-(2-isopropoxyethoxymethyl)-phenoxy]-3-amino-2-propanol to be used as the precursors for the radiosynthesis of [11C]bisoprolol enantiomers was readily accomplished by the use of the corresponding chiral epoxide in three steps starting from the commercially available hydroxybenzyl alcohol. The final labelled product (either (+) or (-)-1-[4-(-isopropoxyethoxymethyl)-phenoxy]-3- [11C]isopropylamino-2-propanol) was obtained in 99% radiochemical purity in 30 min with 15+/-5% (EOS, non-decay corrected) radiochemical yield and 3.5+/-1 Ci/micromol specific radioactivity. Preliminary biological evaluation of the tracer in rats showed that about 30% of heart uptake of [11C](S)-bisoprolol is due to specific binding. The high non-specific uptake in lung might mask the heart uptake, thus precluding the use of [11C](S)-bisoprolol for heart and lung studies by PET. The remarkably high uptake of the tracer in rat brain areas rich of beta-adrenergic receptors such as pituitary (1.8+/-0.3% I.D. at 30 min) was blocked by pre-treatment with the beta-adrenergic antagonists propranolol (45%) and bisoprolol (51%, p<0.05). [11C](S)-bisoprolol deserves further evaluation in other animal models as a putative beta(1) selective radioligand for in vivo investigation of central adrenoceptors.


Subject(s)
Bisoprolol/metabolism , Receptors, Adrenergic, beta/metabolism , Animals , Bisoprolol/chemical synthesis , Bisoprolol/chemistry , Brain/metabolism , Ligands , Lung/metabolism , Male , Myocardium/metabolism , Rats , Rats, Inbred Strains , Stereoisomerism , Tissue Distribution
10.
Appl Radiat Isot ; 54(1): 93-5, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11144258

ABSTRACT

The procedure previously reported for the radiosynthesis of [123I]betaCIT was modified in order to improve both radiochemical yield and purity of betaCIT (2beta-carbomethoxy-3beta(4-iodophenyl) tropane) to be injected for SPECT (Single Photon Emission Computed Tomography) analysis imaging. The overall procedure, involving a HPLC purification step, results in quite good and reproducible yields of a highly purified tracer.


Subject(s)
Brain/diagnostic imaging , Brain/metabolism , Cocaine/chemical synthesis , Dopamine/metabolism , Iodine Radioisotopes , Radiopharmaceuticals/chemical synthesis , Serotonin/metabolism , Tomography, Emission-Computed, Single-Photon/methods , Chromatography, High Pressure Liquid , Cocaine/analogs & derivatives , Cocaine/pharmacokinetics , Humans , Ligands , Radiopharmaceuticals/pharmacokinetics
11.
Neurol Sci ; 21(3): 129-34, 2000 Jun.
Article in English | MEDLINE | ID: mdl-11076000

ABSTRACT

We performed a clinical and genetic study of patients affected by cavernous angiomas (CA) of the nervous system. We examined initial signs and symptoms in sporadic and familial cases. We obtained clinical, neuroimaging and genetic data on 15 Italian patients with CA of the nervous system with positive, doubtful or apparently negative family history. Genetic markers surrounding three different gene regions (7q, 3q and 7p) were analysed. In one small family, genetic linkage was consistent with all chromosome loci. In another family with the unusual association of cerebral and spinal CA, linkage with chromosome 7q and, likely, 7p was excluded, while linkage with locus 3q was possible. Our results indicate that Italian families with CA may show genetic heterogeneity. Non-specific and subtle onset symptoms hide the presence of CA within families. Patients with multiple CA may have silent cerebral lesions confirming the low penetrance of clinical signs in spite of radiological ones.


Subject(s)
Central Nervous System Neoplasms/genetics , Chromosomes, Human, Pair 2 , Chromosomes, Human, Pair 3 , Chromosomes, Human, Pair 7 , Hemangioma, Cavernous, Central Nervous System/genetics , Adolescent , Adult , Age of Onset , Child , Child, Preschool , Family Health , Female , Genetic Linkage , Genetic Markers , Humans , Italy , Male , Middle Aged , Mutation , Pedigree
13.
Int J Pharm ; 204(1-2): 101-9, 2000 Aug 25.
Article in English | MEDLINE | ID: mdl-11011992

ABSTRACT

Erytro-(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[ iso-propylamino]-2-butanol (ICI 118551) a potent clinically used beta2 adrenergic antagonist, was labelled with carbon-11 (t1/2 = 20.4 min) as a potential radioligand for the non-invasive assessment of beta2 adrenergic receptors in the lung with positron emission tomography (PET). The radiolabelled compound was prepared by reductive N-alkylation of its des-isopropyl precursor with [2-11C]acetone. (+/-)-[11C]ICI 118551 was obtained in greater than 98% radiochemical purity in 30 min with a radiochemical yield of 15 + 5% (non-decay corrected) and a specific radioactivity 2.5 +/- 0.5 Ci/micromol. The biological evaluation of racemic erythro (+/-)-[11C]ICI 118551 in rats and Macaca Nemestrina shows a high radioactivity uptake in lung and heart. However, in both animal models no detectable displacement of lung radioactivity concentration was observed after pre-treatment with propranolol or ICI 118551, which indicates that in this organ, radioligand uptake is mostly due to non-specific binding. The biological data suggest that erythro (+/-)-[11C]ICI 118551 is not adequate to be further developed as a tracer for beta2 adrenergic receptor imaging in vivo.


Subject(s)
Adrenergic beta-Antagonists/pharmacokinetics , Carbon Radioisotopes/pharmacokinetics , Lung/metabolism , Propanolamines/pharmacokinetics , Receptors, Adrenergic, beta-2/metabolism , Adrenergic beta-2 Receptor Antagonists , Adrenergic beta-Antagonists/blood , Adrenergic beta-Antagonists/chemical synthesis , Animals , Carbon Radioisotopes/blood , Carbon Radioisotopes/chemistry , Female , Macaca nemestrina , Male , Propanolamines/blood , Propanolamines/chemical synthesis , Rats , Tissue Distribution , Tomography, Emission-Computed
14.
Nucl Med Biol ; 27(2): 177-81, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10773547

ABSTRACT

We evaluated [(11)C]fluvoxamine as a tracer for the serotonin re-uptake site. Studies of the distribution of the tracer in rat and primate brain showed adequate uptake of [(11)C]fluvoxamine, but failed to reveal regions with known high density of serotoninergic re-uptake sites. Pretreatment with unlabeled fluvoxamine did not substantially change the distribution. In rat brain tissue, nearly all radioactivity represented intact [(11)C]fluvoxamine. [(11)C]Fluvoxamine does not function as a tracer for serotonin re-uptake sites, owing to high nonspecific binding in the brain.


Subject(s)
Fluvoxamine/analogs & derivatives , Radiopharmaceuticals , Receptors, Serotonin/metabolism , Selective Serotonin Reuptake Inhibitors , Serotonin/metabolism , Animals , Biotransformation , Brain/diagnostic imaging , Brain/metabolism , Fluvoxamine/pharmacokinetics , Macaca nemestrina , Male , Radiopharmaceuticals/pharmacokinetics , Rats , Selective Serotonin Reuptake Inhibitors/pharmacokinetics , Tissue Distribution , Tomography, Emission-Computed
15.
Neuroradiology ; 41(4): 249-54, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10344508

ABSTRACT

Contrast medium was given intravenously to three nonalcoholic patients who underwent MRI or CT in the acute stage of Wernicke's encephalopathy. Lesions enhancement was not seen in one patient examined within 4 days of clinical onset, was mild in a another 3 days after clinical deterioration and marked in a patient examined 12 days after admission. Contrast enhancement of lesions was present in half of 12 cases of acute disease reported previously. There was a substantial overlap in the time interval between clinical onset and contrast-enhanced CT or MRI in the groups of enhancing and nonenhancing lesions. Since contrast enhancement may be absent in acute WE, proton-density and T2-weighted images are more useful for diagnosis of this reversible but potentially fatal condition.


Subject(s)
Contrast Media , Image Enhancement/methods , Magnetic Resonance Imaging/methods , Radiographic Image Enhancement/methods , Tomography, X-Ray Computed/methods , Wernicke Encephalopathy/diagnosis , Acute Disease , Contrast Media/administration & dosage , Female , Follow-Up Studies , Gadolinium DTPA/administration & dosage , Humans , Injections, Intravenous , Male , Middle Aged , Wernicke Encephalopathy/diagnostic imaging
17.
Radiol Med ; 91(6): 769-73, 1996 Jun.
Article in Italian | MEDLINE | ID: mdl-8830364

ABSTRACT

The authors report their early personal experience with double-helix spiral CT (CT Twin Elscint) in the study of liver metastases. This work was aimed at optimizing the study technique and at assessing the diagnostic accuracy of this method. The high temperature developed by CT Twin and the presence of a double row of detectors permit to acquire proper length sequences (with 6.5 mm slice thickness) within a short scanning time which is easy for the patient to tolerate without breathing and moving. Two hundred and thirty patients were examined with US for focal hepatic lesions and then submitted to spiral CT: spatial and density resolution were higher with spiral CT than with US, and the former technique permitted the whole liver to be studied without any partial volume artifacts, which allowed us to confirm all the lesions depicted with US and to detect other lesions, missed at US, in 20% of patients. The choice of the proper time between contrast administration and sequence acquisition is sufficient to permit the detection of focal lesions, if the liver is studied in the portal phase. The authors stress the yield of spiral CT, especially with the double-helix technique, in studying liver metastases.


Subject(s)
Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Tomography, X-Ray Computed/instrumentation
18.
Angiology ; 46(4): 321-6, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7726452

ABSTRACT

The authors prospectively studied the feasibility and safety of high-dose dipyridamole echocardiography in 166 patients (77 younger and 89 elderly patients) referred for clinical evaluation of coronary artery disease. Echocardiographic examinations were adequate for analysis of parameters considered in 135 of the 166 patients (81.3%; 73 elderly, 62 younger patients). The feasibility of dipyridamole echocardiography test was 80.5% in young and 82% in elderly patients (P = ns). The incidence of side effects during dipyridamole echocardiography was similar in the two groups, except for dyspnea, which was observed in 20.5% of older and 3.2% of younger patients (p < 0.05). These data demonstrate that the dipyridamole test combined with echocardiographic monitoring of regional myocardial contractility may be considered a valid noninvasive method of evaluating coronary artery disease in the elderly.


Subject(s)
Coronary Disease/diagnostic imaging , Coronary Disease/physiopathology , Dipyridamole/adverse effects , Echocardiography/adverse effects , Adult , Aged , Aged, 80 and over , Feasibility Studies , Female , Humans , Male , Middle Aged , Prospective Studies
19.
Minerva Cardioangiol ; 42(11): 511-5, 1994 Nov.
Article in Italian | MEDLINE | ID: mdl-7700540

ABSTRACT

The carotid artery is one of the most important sites in the progression of atherosclerotic lesions. Atherosclerosis is known to be determined by a variety of factors, among which arterial hypertension is one of the most important. Blood pressure control by antihypertensive treatment is thus of great benefit in management of atherosclerosis, particularly in view of the direct action of some classes of antihypertensive agents on atheromatous lesions. Today, modern diagnostic technique allow a non-invasive examination of the artery wall (B-mode ultrasound and pulsed-Doppler), so that early detection of structural and functional alterations is possible. In order to evaluate the efficacy of the long term blood pressure reduction in the progression and/or in the regression of cardiovascular structural abnormalities, we studied intima-media thickness and arterial compliance during one-year antihypertensive treatment with a new calcium-antagonist, lacidipine, or a diuretic hydrochlorothiazide. In both groups we observed a comparable blood pressure reduction (lacidipine: from 166 +/- 5/100 +/- 1 to 142 +/- 4/88 +/- 2 mmHg; hydrochlorothiazide: from 154 +/- 5/102 +/- 2 to 140 +/- 4/88 +/- mmHg; both p < 0.01). On the contrary, only in patients treated with lacidipine did we obtain a significant improvement in carotid blood flow (383 +/- 16 vs 411 +/- 16 ml/min p <) and in arterial compliance (0.8 +/- 0.1 vs 1.2 +/- 0.2 cm/dyne p < 0.01). Indeed, we observed a different behaviour of the intima-media thickness in the two groups (lacidipine: 1.11 +/- 1.4 vs 1.13 +/- 1.5 mm n.s.; hydrochlorothiazide: 1.15 +/- 0.15 vs 1.21 +/- 0.17 mm p < 0.06). Our results demonstrate that an effective antihypertensive treatment with calcium antagonists may influence the progression of carotid vascular abnormalities.


Subject(s)
Antihypertensive Agents/pharmacology , Calcium Channel Blockers/pharmacology , Carotid Arteries/drug effects , Dihydropyridines/pharmacology , Hydrochlorothiazide/pharmacology , Tunica Intima/drug effects , Aged , Antihypertensive Agents/administration & dosage , Blood Circulation/drug effects , Blood Pressure/drug effects , Calcium Channel Blockers/administration & dosage , Carotid Arteries/diagnostic imaging , Carotid Stenosis/diagnostic imaging , Dihydropyridines/administration & dosage , Female , Humans , Hydrochlorothiazide/administration & dosage , Hypertension/drug therapy , Male , Middle Aged , Time Factors , Tunica Intima/diagnostic imaging , Ultrasonography, Doppler , Vascular Resistance/drug effects
20.
Proc Natl Acad Sci U S A ; 91(24): 11378-82, 1994 Nov 22.
Article in English | MEDLINE | ID: mdl-7972068

ABSTRACT

To determine whether human immunodeficiency virus type 1 (HIV-1) strains in the lungs of infected individuals are derived from proviral forms contemporaneously present in the peripheral blood or whether they evolve independently as an autonomous pool of viral quasispecies, HIV-1 envelope V3 domain structures at these sites were analyzed and compared. The V3 loop proviral nucleotide and inferred amino acid sequences from lung bronchoalveolar lavage, where HIV-1 is primarily found in macrophages, were more homogeneous within individuals than those from unseparated peripheral blood mononuclear cells, where virus is predominantly in T cells. Comparison between individuals revealed that strains from bronchoalveolar lavage, but not from peripheral blood mononuclear cells, contained V3 domain nucleotide sequences with a great degree of homogeneity in the C-terminal region and a highly conserved, negatively charged amino acid motif. This V3 loop C-terminal structure could be important in the ability of HIV-1 to infect alveolar macrophages. Phylogenetic analyses of V3 domain nucleotide sequences in cells of monocyte/macrophage lineage at both sites revealed the strains in lung macrophages to have evolved further from a presumed ancestral species than those in blood monocytes and to differ considerably in the inferred V3 loop amino acid structures. These results show that, as disease progression occurs, viral strains in monocyte/macrophage lineage cells within the lung and blood microenvironments are not in a state of unrestricted bidirectional traffic but, instead, evolve independently.


Subject(s)
HIV Envelope Protein gp120/genetics , HIV Infections/microbiology , Lung/microbiology , Amino Acid Sequence , Base Sequence , Bronchoalveolar Lavage Fluid/microbiology , Consensus Sequence , DNA Primers/chemistry , Humans , Leukocytes, Mononuclear/microbiology , Molecular Sequence Data , Phylogeny , Proviruses/genetics , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...